New Delhi, April 11
The Centre on Sunday prohibited exports of Remdesivir injection and active pharmaceutical ingredients until the Covid-19 situation stabilised in the country.
The government said India was witnessing a surge in cases and as of Sunday, there were 11.08 lakh active cases, and counting. “This has led to a sudden spike in demand for Remdesivir injection used in Covid treatment. There is a potential of further increase in this demand in the coming days,” the government said, banning exports for now.
The government also said it had taken steps to ensure easy access of hospitals and patients to Remdesivir. — TNS
7 companies making it
- Seven Indian firms are producing Remdesivir injection
- They have licensing agreement with Gilead Sciences, US
- Have an installed capacity of about 38.80 lakh units per month